Exponent, Inc. (EXPO)
Last Price$83.1(1.2%)
Market Cap$4,238.0M
EXPO Rating
EXPO Quality rating performance
EXPO Intrinsic Value
Key Highlights:
As of Mar 11, 2025 EXPO Relative Value is $36.5, which is overvalued by 56.0%, compared to current share price of $83.1.
As of Mar 11, 2025 EXPO DCF Value is $28.4, which is overvalued by 65.8%, compared to current share price of $83.1.
EXPO Share Price History
1W 0.2%
1M (8.4%)
6M (20.0%)
YTD (7.2%)
1Y 5.8%
3Y (8.9%)
5Y 15.5%
10Y 330.5%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
EXPO Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$4,238.0M
$4,060.6M
$558.5M
$137.6M
Shares Outstanding
51M
Employees
1,168
Growth (CAGR)
6.0%
6.43%
10.1%
(4.6%)
(6.80%)
Profitability
60.7%
21.4%
19.5%
25.9%
24.6%
126.2%
Intrinsic Value
$32.4 (61.0% overvalued)
$28.3
$36.6
25.4%
Valuation (LTM)
Return on Capital
Financial Health
($177.4M)
(1.3x)
19.4%
Dividends
13.5%
1.4%
42.3%
Mar 07, 2025
Earnings
Jul 23, 2025
BEAT by 12.6%
BEAT by 13.0%
(4.2%)
6 Beat & 4 Miss
EXPO Stock Financials
EXPO Income Statement Metrics
Annual
Quarterly
LTM
EXPO Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$144.5M +13.5% YoY
Capital Expenditure (CAPEX)
($6,939.0K) -57.6% YoY
Free Cash Flow (FCF)
$137.6M +24.0% YoY
EXPO Income Statement Overview
Annual
Quarterly
LTM
Jan'16
Dec'16
Dec'17
Dec'18
Jan'20
Jan'21
Dec'21
Dec'22
Dec'23
Jan'25
$558.5M 4.1% YoY
Pre-tax income
$147.4M 8.4% YoY
26.4% margin
EXPO Balance Sheet Overview
Annual
Quarterly
LTM
Jan'16
Dec'16
Dec'17
Dec'18
Jan'20
Jan'21
Dec'21
Dec'22
Dec'23
Jan'25
Assets
Liabilities
Total assets
$777.3M
Current assets ($446.9M, 57.5% of total)
$258.9M (33.3%)
$161.4M (20.8%)
Other current assets
$26.6M (3.4%)
Non-current assets ($330.4M, 42.5% of total)
$0.0 (0.0%)
$148.3M (19.1%)
$0.0 (0.0%)
Other non-current assets
$182.1M (23.4%)
Financial position
($177.4M)
Cash & Short-term
Investments
Total Debt
EXPO Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
EXPO Earnings Surprises
Crunching data... Almost there!
EXPO Dividends
EXPO Dividend Yield
Crunching data... Almost there!
EXPO Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with EXPO
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$4,238.0M | 6.6 | $32.4 61.0% overvalued | 5.8% | $558.5M | $137.6M | 4.1% | 24.6% | 60.7% | 26.4% | 19.4% | |
$41.5B | 7.3 | $198.7 31.6% overvalued | 23.1% | $2,881.7M | $920.1M | 7.5% | 31.9% | 63.4% | 48.7% | 0.0% | |
$30.3B | 6.6 | $116.9 51.2% overvalued | (8.5%) | $5,681.1M | $813.0M | 7.9% | 14.3% | 55.7% | 7.6% | 101.8% | |
$15.9B | 6.4 | $52.3 36.4% overvalued | 3.6% | $4,183.8M | $503.2M | 9.2% | 12.0% | 60.0% | 6.2% | 120.7% | |
$13.9B | 6.8 | $152.1 38.2% undervalued | (22.8%) | $11.8B | $844.2M | 14.1% | 7.2% | 39.2% | 21.2% | 28.6% | |
$5,790.0M | 5.6 | $192.0 17.7% undervalued | (20.0%) | $3,698.7M | $359.7M | 6.0% | 9.7% | 31.9% | 10.4% | 10.7% | |
$2,572.4M | 6.9 | $125.6 13.7% overvalued | 46.4% | $1,521.8M | $168.7M | 8.8% | 11.1% | 48.7% | 10.7% | 12.1% | |
$1,648.8M | 5.8 | $164.2 87.2% undervalued | (42.7%) | $2,019.8M | $150.1M | 2.9% | 7.4% | 35.9% | 7.6% | 61.3% | |
$1,194.8M | 6.4 | $134.1 25.8% overvalued | 30.1% | $687.4M | $33.1M | 10.2% | 4.8% | 29.4% | 11.9% | 39.9% | |
$409.6M | 7.2 | $41.3 33.5% undervalued | (21.0%) | $287.9M | $48.4M | 3.0% | 16.8% | 75.5% | 23.6% | 3.6% | |
$232.7M | 4.2 | $36.5 431.2% undervalued | (46.8%) | $582.1M | $22.9M | (17.4%) | 3.9% | 37.4% | (18.2%) | 3.3% |
FAQ
What is Exponent, Inc. (EXPO) stock rating?
As of today, Exponent, Inc. has a stock rating of 7 (out of 10), which is considered Good.
is Exponent, Inc. (EXPO) a good stock to buy?
As of today, Exponent, Inc. has a Good stock rating, which is 61.0% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.